Abstract

Granulocyte/macrophage colony-stimulating factor (GM-CSF) promotes the survival, proliferation, and differentiation of myeloid lineage cells and regulates chemotaxis and adhesion. However, mice in which the genes encoding GM-CSF (Gmcsf) or the β common subunit of the GM-CSF receptor (βc) are inactivated display normal steady-state hematopoiesis. Here, we show that host GM-CSF signaling strongly modulates the ability of donor hematopoietic cells to radioprotect lethally irradiated mice. Although bone marrow mononuclear cells efficiently rescue Gmcsf mutant recipients, fetal liver cells and Sca1+ lin−/dim marrow cells are markedly impaired. This defect is partially attributable to accessory cells that are more prevalent in bone marrow. In contrast, Gmcsf-deficient hematopoietic stem cells demonstrate normal proliferative potentials. Short-term survival is also impaired in irradiated βc mutant recipients transplanted with fetal liver or bone marrow. These data demonstrate a nonredundant function of GM-CSF in radioprotection by donor hematopoietic cells that may prove relevant in clinical transplantation.

Highlights

  • We show that host Granulocyte/macrophage colony-stimulating factor (GM-CSF) signaling strongly modulates the ability of donor hematopoietic cells to radioprotect lethally irradiated mice

  • Transplantation protocols utilize bone marrow, mobilized peripheral blood stem cells (PBSCs), and umbilical cord blood as sources of Hematopoietic stem cell (HSC), and intrinsic variations in HSCs derived from different sources have been reported previously [1]

  • The source of HSCs modulates the duration of posttransplant cytopenia with cytokine-mobilized PBSCs inducing the most rapid recovery and umbilical cord blood cells inducing the slowest [2, 3]

Read more

Summary

The Journal of Experimental Medicine

We show that host GM-CSF signaling strongly modulates the ability of donor hematopoietic cells to radioprotect lethally irradiated mice. Short-term survival is impaired in irradiated ␤c mutant recipients transplanted with fetal liver or bone marrow. These data demonstrate a nonredundant function of GM-CSF in radioprotection by donor hematopoietic cells that may prove relevant in clinical transplantation. We previously observed poor survival of irradiated GmcsfϪրϪ mice that were transplanted with fetal liver cells doubly mutant at the Gmcsf and Nf1 loci [13]. We show that donor accessory cells and host GM-CSF signaling strongly modulate radioprotection These data, which define the first essential role for GM-CSF in hematopoiesis, may prove relevant for enhancing HSCT

RESULTS AND DISCUSSION
WT ϩ
MATERIALS AND METHODS

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.